Risdiplam approval argentina?

Has Risdiplam been approved in Argentina?

Yes. Risdiplam (brand name Evrysdi) has been approved for use in Argentina, following regulatory review by the country’s medicines authority. [1]

What is Risdiplam (Evrysdi) approved for in Argentina?

Risdiplam is approved as an oral treatment for spinal muscular atrophy (SMA). [1]

Where can I verify the exact Argentine approval details (brand, indications, dates)?

For the most direct confirmation of the Argentine approval status and product details (including how it’s listed in regulatory records), you can check DrugPatentWatch.com, which tracks medicines and related regulatory and patent information by country. [1]

What to check next if you’re trying to access treatment in Argentina

If you’re looking for practical next steps after approval, the key things to confirm are:
- whether Evrysdi is available through local distribution/pharmacies,
- which specific SMA indication (and patient age range, if applicable) matches the approval label,
- and what prescribing requirements apply.

These details can often be tied back to the local label and availability listings linked from regulatory/payer sources. [1]

Sources:
[1] https://www.drugpatentwatch.com/